B2GL19 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihiphdx7itbolmiwnq5wmxiwktsktfmysclbamzyzsipvrypwuyy4/metadata.json
IPFS of structure file: 
bafybeic3cccivzeax5oubmrqt23yd6dkq2irfb2poyaxnyr5ev7nh6an5i/AF-B2GL19-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9b4fafb91E864e57DfbcD53390687C2E0DC9e291
First NFT owner address (bech32): 
genesis1nd86lwg7se890hau65eeq6ru9cxunc53c5765g
Current NFT ID #166677 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166677
Accession (UniProt):
B2GL19
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Kocuria rhizophila (strain ATCC 9341 / DSM 348 / NBRC 103217 / DC2201)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2GL19 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2GL19|HEM1_KOCRD Glutamyl-tRNA reductase OS=Kocuria rhizophila (strain ATCC 9341 / DSM 348 / NBRC 103217 / DC2201) OX=378753 GN=hemA PE=3 SV=1 MVLFCLVASHRTVDLNTVARLSTGALGVAEDAVSRGALAGAITLSTCNRLELYGELPEHASVDVPGAQQQLAERIARRAGLDERFVLETMDAYEGPEVPRHLFTVVSGLESAVVGEREITGQVRRALAGAQQSGTASPHLVQLFEAAARTAREVGASTGLGERGRSIVSVALDLADDITSGDWPERHALVFGTGAYAGATMAALRDRGCADIEVYSGSGRAQQFTDQRGGSPVTDESLPGALRRADVIIGCSGGSAPMPASRFPAGPRTVVDLALARDFDPAVADLPNVELITLESVRVAAPEETRESVAAAREIVERAARDFENARTARSMDQAIVALRKHTMAVLDAELDKVRTHHGCTGAEEQIEMAMRRMVRSLLHTPTVRARQLAAEGRADEYITGLEALYGLEVAVPDVPEETAPSTRQDPSDTPRPRAVG